The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides got reclassified the moment they started threatening real revenue. Not because new safety data emerged. Not because patients started getting hurt. The moment pharma noticed people were healing tendons, sleeping better, FDA Removes 12 Peptides from 503A Category 2 : r us_pharmacies The peptide conversation is shifting. Secretary RFK Jr. recently announced that the FDA plans to move 14 peptides from Category 2 back to Category 1 restoring FDA recognized status and making them